Abdullah Sonsuz et al. 2022. Efficacy and Safety of Ombitasvir/Paritaprevir/ Ritonavir + Dasabuvir ± Ribavirin Combinations in Patients with Genotype 1 Hepatitis C and Inherited Bleeding Disorders. Turkish Journal of Gastroenterology. 33, 5 (May 2022), 414–420.